Globalink Investment Inc. is a special purpose acquisition company (SPAC) incorporated in 2021 and headquartered in Newark, Delaware. The company is formed for the purpose of effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with one or more businesses. Globalink primarily targets companies positioned to benefit from technological developments in the medical technology and green energy sectors. Its geographic focus includes North America, Europe, Southeast Asia, and Asia excluding China, Hong Kong, and Macau. As a SPAC, Globalink does not have significant standalone operations or generate revenue on its own.
Recently, Globalink Investment Inc. completed a major business combination with Alps Life Sciences through a two-step merger process resulting in Alps Life Sciences becoming a wholly owned subsidiary of the merged entity. The transaction, approved by Globalink’s stockholders in October 2025, marked a significant strategic shift by transitioning from a blank check company to an operational entity in the life sciences industry. This business combination aligns with Globalink’s investment focus on medical technology and green energy sectors. The company has extended the deadline multiple times to complete its initial business combination, reflecting careful execution and regulatory compliance.
Globalink Investment Inc.’s core operations now revolve around strategic asset management and investments in sectors aligned with technological innovation in health sciences and environmentally sustainable energy solutions. The company serves institutional and private investors seeking exposure to these targeted industries through a focused acquisition strategy. Its parent company is GL Sponsor LLC, and Globalink conducts governance and operational activities from its Newark, Delaware headquarters.